Cargando…
Glucuronidation and UGT isozymes in bladder: new targets for the treatment of uroepithelial carcinomas?
Bladder cancer has been linked to numerous toxins which can be concentrated in the bladder after being absorbed into the blood and filtered by the kidneys. Excessive carcinogenic load to the bladder urothelium may result in the development of cancer. However, enzymes within the bladder can metaboliz...
Autores principales: | Sundararaghavan, Vikram L., Sindhwani, Puneet, Hinds, Terry D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356909/ https://www.ncbi.nlm.nih.gov/pubmed/27690298 http://dx.doi.org/10.18632/oncotarget.12277 |
Ejemplares similares
-
Bilirubin, a new therapeutic for kidney transplant?
por: Sundararaghavan, Vikram L., et al.
Publicado: (2018) -
Chromosomal changes in uroepithelial carcinomas
por: Fadl-Elmula, Imad
Publicado: (2005) -
Giant hydronephrosis complicated by multiple uroepithelial carcinomas
por: Song, Zhen, et al.
Publicado: (2021) -
Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer
por: Chiu, Melody, et al.
Publicado: (2017) -
Regioselective Glucuronidation of Diosmetin and Chrysoeriol by the Interplay of Glucuronidation and Transport in UGT1A9-Overexpressing HeLa Cells
por: Zeng, Xuejun, et al.
Publicado: (2016)